Michelle specialises in new ventures and health technology commercialisation. Her role is to fast-track new technologies towards market and patient impact.
A former MedTech startup founder herself, Michelle Kleynhans is an experienced manager across new technology ventures, investment, and the design and delivery of commercialisation programs for early-stage healthcare startups and scientists.
With an interdisciplinary background in business and science, Michelle is passionate about supporting early-stage technologies turn into successful businesses, and driving lasting impact in Australia.
The Genomical team acknowledges the Wurundjeri, Gunaikurnai and all First Nations peoples on whose lands we live and work. We pay respect to their Elders, past and present. We also acknowledge the First Nations scientists, researchers and leaders who are shaping the future of genomic medicine.